Hancock Holding Co. Takes Position in Transcat, Inc. (TRNS)

Hancock Holding Co. purchased a new position in Transcat, Inc. (NASDAQ:TRNS) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 18,651 shares of the scientific and technical instruments company’s stock, valued at approximately $292,000. Hancock Holding Co. owned approximately 0.26% of Transcat at the end of the most recent reporting period.

A number of other hedge funds also recently added to or reduced their stakes in the stock. UBS Group AG raised its stake in Transcat by 62.9% in the first quarter. UBS Group AG now owns 66,465 shares of the scientific and technical instruments company’s stock worth $1,040,000 after buying an additional 25,664 shares in the last quarter. Dimensional Fund Advisors LP raised its stake in Transcat by 2.8% in the first quarter. Dimensional Fund Advisors LP now owns 316,063 shares of the scientific and technical instruments company’s stock worth $4,946,000 after buying an additional 8,621 shares in the last quarter. Quantum Capital Management raised its stake in Transcat by 31.6% in the first quarter. Quantum Capital Management now owns 83,824 shares of the scientific and technical instruments company’s stock worth $1,312,000 after buying an additional 20,110 shares in the last quarter. Deutsche Bank AG raised its stake in Transcat by 86.8% in the fourth quarter. Deutsche Bank AG now owns 33,695 shares of the scientific and technical instruments company’s stock worth $480,000 after buying an additional 15,653 shares in the last quarter. Finally, Renaissance Technologies LLC raised its stake in Transcat by 118.8% in the fourth quarter. Renaissance Technologies LLC now owns 53,394 shares of the scientific and technical instruments company’s stock worth $761,000 after buying an additional 28,994 shares in the last quarter. 53.64% of the stock is owned by institutional investors.

A number of equities analysts recently issued reports on the stock. Zacks Investment Research raised shares of Transcat from a “hold” rating to a “buy” rating and set a $22.00 price target for the company in a research note on Friday. ValuEngine raised shares of Transcat from a “hold” rating to a “buy” rating in a research note on Wednesday, April 11th. Five research analysts have rated the stock with a buy rating, Transcat currently has a consensus rating of “Buy” and a consensus target price of $20.50.



Shares of TRNS opened at $20.10 on Friday. The stock has a market capitalization of $141.79 million, a price-to-earnings ratio of 28.31, a price-to-earnings-growth ratio of 2.65 and a beta of 0.42. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.38 and a current ratio of 1.92. Transcat, Inc. has a fifty-two week low of $11.80 and a fifty-two week high of $21.10.

Transcat (NASDAQ:TRNS) last announced its quarterly earnings data on Wednesday, May 23rd. The scientific and technical instruments company reported $0.27 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.23 by $0.04. The business had revenue of $42.45 million for the quarter, compared to analysts’ expectations of $40.70 million. Transcat had a net margin of 3.82% and a return on equity of 10.83%. equities analysts predict that Transcat, Inc. will post 0.93 earnings per share for the current year.

In other Transcat news, Chairman Charles P. Hadeed sold 17,700 shares of the company’s stock in a transaction dated Wednesday, May 30th. The shares were sold at an average price of $18.18, for a total value of $321,786.00. Following the sale, the chairman now owns 77,474 shares in the company, valued at $1,408,477.32. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Alan H. Resnick sold 1,916 shares of the company’s stock in a transaction dated Friday, June 8th. The stock was sold at an average price of $19.79, for a total transaction of $37,917.64. Following the completion of the sale, the director now owns 35,400 shares in the company, valued at approximately $700,566. The disclosure for this sale can be found here. 8.80% of the stock is currently owned by corporate insiders.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates in two segments, Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualifications, preventative maintenance, consulting, and other related services.

Want to see what other hedge funds are holding TRNS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Transcat, Inc. (NASDAQ:TRNS).

Institutional Ownership by Quarter for Transcat (NASDAQ:TRNS)

Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply